Which Patient Is at Greatest Risk for Developing a Hematologic

Which patient is at greatest risk for developing a hematologic problem while receiving rasburicase?

A) 32-year-old patient taking chemotherapy for kidney cancer
B) 42-year-old patient who has a glucose-6-phosphate dehydrogenase deficiency
C) 52-year-old patient who has a deficiency of the enzyme alpha-1-antitrypsin
D) 62-year-old patient who was first diagnosed with gout at the age of 21 years